- Forums
- ASX - By Stock
- MYX
- Ann: MAYNE PHARMA provides FDA update on generic NUVARING
Ann: MAYNE PHARMA provides FDA update on generic NUVARING, page-42
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.11 |
Change
0.010(0.20%) |
Mkt cap ! $434.7M |
Open | High | Low | Value | Volume |
$5.10 | $5.17 | $4.91 | $719.0K | 141.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 1071 | $5.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.13 | 47 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1047 | 5.110 |
5 | 471 | 5.100 |
3 | 1009 | 5.090 |
3 | 5476 | 5.080 |
3 | 2403 | 5.070 |
Price($) | Vol. | No. |
---|---|---|
5.130 | 158 | 5 |
5.140 | 533 | 2 |
5.150 | 469 | 2 |
5.160 | 1549 | 4 |
5.170 | 2891 | 3 |
Last trade - 14.01pm 11/11/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online